The OPP Branch promotes research to improve the safety and efficacy of pharmaceuticals and to ensure centralization and coordination of research, clinical trials, and drug development activities for obstetric and pediatric populations. The Best Pharmaceuticals for Children Act (BPCA) activities at the NICHD is a major activity for the Branch, which is responsible for developing and supporting a comprehensive national effort to increase the knowledge base for understanding how to appropriately treat disease during pregnancy, infancy, and childhood using pharmaceuticals that are appropriately tested within their target populations.
Frequently Asked Questions (FAQs) About RFA HD-10-026: Specialized Centers in Research in Pediatric Developmental Pharmacology Program (U54)
=
